诊断学理论与实践 ›› 2021, Vol. 20 ›› Issue (01): 66-70.doi: 10.16150/j.1671-2870.2021.01.010

• 论著 • 上一篇    下一篇

9株分离自住院患者的CA-MRSA基因型菌株的分子特征及耐药性研究

王院霞, 姚锂凤, 郑巧平, 陈旭()   

  1. 上海交通大学医学院附属第九人民医院检验科,上海 200011
  • 收稿日期:2020-10-13 出版日期:2021-02-25 发布日期:2022-06-28
  • 通讯作者: 陈旭 E-mail:chenxu917@hotmail.com
  • 基金资助:
    上海市卫计委青年项目(20184Y0025);上海市青年科技英才扬帆计划(19YF1427500);上海市“医苑新星”青年医学人才培养计划

Molecular characterization and antimicrobial resistance of nine strains of CA-MRSA isolated from clinical inpatients

WANG Yuanxia, YAO Lifeng, ZHENG Qiaoping, CHEN Xu()   

  1. Department of Laboratory Medicine, Shanghai Ninth People′s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China
  • Received:2020-10-13 Online:2021-02-25 Published:2022-06-28
  • Contact: CHEN Xu E-mail:chenxu917@hotmail.com

摘要:

目的:分析分离自住院患者的社区获得耐甲氧西林金黄色葡萄球菌(community-associated methicillin resistant Staphylococcus aureus, CA-MRSA)菌株的分子水平特征和耐药性,为监测CA-MRSA的流行及治疗、控制提供依据。方法:收集2014年4月到2015年12月期间从住院患者标本(入院后48 h内获取)中分离的金黄色葡萄球菌,检测其mecA基因以区分耐甲氧西林金黄色葡萄球菌(methicillin resistant Staphylococcus aureus, MRSA)与甲氧西林敏感的金黄色葡萄球菌(methicillin sensitive Staphylococcus aureus, MSSA),并根据葡萄球菌盒式染色体基因mec(Staphylococcal cassette chromosome mec, SCCmec)的携带情况,筛选CA-MRSA基因型菌株。采用金黄色葡萄球菌A蛋白(Staphylococcal protein A, SPA)基因分型、多位点序列分型(multilocus-sequence typing, MLST)等方法分析CA-MRSA菌株的分子水平特征;根据美国临床和实验室标准研究所(Clinical and Laboratory Standards Institute, CLSI)指南,采用纸片扩散法检测CA-MRSA菌株的药物敏感性,并对CA-MRSA菌株是否携带杀白细胞素基因(panton-valentine leukocidin gene, pvl基因)进行检测。结果:共收集到147株金黄色葡萄球菌,其中MRSA 58株,根据SCCmec分型结果,共有9株CA-MRSA,包括SCCmec Ⅳ 3株、SCCmecⅤ 6株。9株CA-MRSA菌株对多种非β-内酰胺类抗生素耐药,其中有8株对红霉素和克林霉素耐药,主要是由红霉素核糖体甲基化酶(erythromycin ribosomal methylase, erm(B)基因介导;有8株对氨基糖苷类药物(主要为卡那霉素)耐药。对9株CA-MRSA菌株进行分子流行病学特征分析后发现,CA-MRSA主要以t437-ST59克隆为主,其他还有t034-ST804、t127-ST1、t008-ST8、t437-ST338等克隆;9株CA-MRSA菌株中,有5株携带毒力基因pvl结论:致病性较强的CA-MRSA菌株逐渐进入医疗环境中,且对非β-内酰胺类药物的耐药性也逐渐增加,应加强对住院患者CA-MRSA分离株的监控。

关键词: 社区获得耐甲氧西林金黄色葡萄球菌, 分子特征, 耐药性

Abstract:

Objective: To investigate the molecular characterization and antimicrobial resistance of CA-MRSA(community-associated methicillin-resistant Staphylococcus aureus) strains isolated from clinical inpatientsto provide evidence for prevention and treatment of CA-MRSA infections. Methods: Isolates of S. aureus from hospitalized patients were collected within 24 h after admission from April 2014 to Dec. 2015, and mecA gene was detected to distinguish MRSA from MSSA (methicillin-sensitive Staphylococcus aureus). Genotypic CA-MRSA strains carrying SCC mec Ⅳ/Ⅴ were obtainedfor further analysis of molecular epidemiologic characters by spa-typing and MLST(multilocus -sequence typing). Based on the CLSI (Clinical and Laboratory Standards Istitute) guidelines, disk diffusion method was used to test drug susceptibility of CA-MRSA strains. Moreover, the presence of pvl virulence gene was detected by PCR. Results: A total of 147 strains of S. aureus including 58 MRSA strains were collected from hospitalized patients. By SCCmec typing, 9 CA-MRSA strains (SCCmec Ⅳ 3; SCCmec Ⅴ 6) were detected. All CA-MRSA strains developed resistance against different non-β-lactams, among which 8 strains developed drug-resistanceagainst aminoglycosides (mainly kanamycin) and 8 strains developed drug-resistance against erythromycin and clindamycin mediated by erm(B) mainly. Molecular typing revealed that the main CA-MRSA clone was t437-ST59, and other clones were t034-ST804, t127-ST1, t008-ST8 and t437-ST338. In addition, 5 out of 9 CA-MRSA strains were pvl gene positive. Conclusions: More pathogenic CA-MRSA strains are invading healthcare-associated settings and developing more resistance against non-β-lactams, indicating that the CA-MRSA should be closely monitored in hospitals.

Key words: Community-associated methicillin resistant Staphylococcus aureus, Molecular characterization, Antimicro-bial resistance

中图分类号: